Clinical Trials for Hanmi Pharmaceutical

A SAD Study of HM17321 in Healthy Adult Participants

A Phase 2 Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease

Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

Dose Escalation and Expansion Study of HM16390 in Advanced or Metastatic Solid Tumors

A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors

Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy

Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects

Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque